S2Medical AB (publ) (STO:S2M)

S2Medical AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	14.68	7.72	6.16	10.63	27.53
Other Revenue	-	-	-	-	0.44
Revenue	14.68	7.72	6.16	10.63	27.97
Revenue Growth (YoY)	90.03%	25.39%	-42.08%	-61.98%	399.50%
Cost of Revenue	0.77	2.69	0.99	3.54	17.48
Gross Profit	13.91	5.04	5.17	7.1	10.48
Selling, General & Admin	14.99	19.14	31.54	25.54	23.06
Other Operating Expenses	-7.22	-0.57	-0.61	-0.1	1.18
Operating Expenses	9.08	20.3	32.85	26.93	25.55
Operating Income	4.83	-15.26	-27.69	-19.84	-15.06
Interest Expense	-0.02	-7.44	-1.77	-0.24	-0.07
Interest & Investment Income	0	0	-	-	0
Pretax Income	4.81	-22.71	-29.46	-20.08	-15.13
Net Income	4.81	-22.71	-29.46	-20.08	-15.13
Net Income to Common	4.81	-22.71	-29.46	-20.08	-15.13
Shares Outstanding (Basic)	560	121	24	15	12
Shares Outstanding (Diluted)	560	121	24	15	12
Shares Change (YoY)	360.86%	411.02%	60.30%	26.41%	3.86%
EPS (Basic)	0.01	-0.19	-1.24	-1.35	-1.29
EPS (Diluted)	0.01	-0.19	-1.24	-1.35	-1.29
Free Cash Flow	5.03	-16.52	-28.34	-19.85	-13.04
Free Cash Flow Per Share	0.01	-0.14	-1.19	-1.34	-1.11
Gross Margin	94.79%	65.22%	83.86%	66.74%	37.49%
Operating Margin	32.89%	-197.63%	-449.53%	-186.54%	-53.85%
Profit Margin	32.78%	-294.00%	-478.23%	-188.83%	-54.12%
Free Cash Flow Margin	34.28%	-213.89%	-460.08%	-186.70%	-46.64%
EBITDA	5.52	-14.14	-26.37	-18.73	-14.14
EBITDA Margin	37.61%	-183.02%	-	-176.11%	-50.56%
D&A For EBITDA	0.69	1.13	1.32	1.11	0.92
EBIT	4.83	-15.26	-27.69	-19.84	-15.06
EBIT Margin	32.89%	-197.63%	-	-186.54%	-53.85%
Revenue as Reported	22.33	8.45	8.93	11.5	28.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.